DALLAS, June 30 /PRNewswire-USNewswire/ -- The American Heart Association has set August for the premier of Circulation: Cardiovascular Interventions, the fourth in a series of six new titles to be published under the banner of Circulation: Journal of the American Heart Association. The journals will be published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
David P. Faxon, M.D., has been named editor of the new journal. Faxon is director of strategic planning in the department of medicine at Brigham and Women's Hospital, Boston, and chief of cardiology at West Roxbury (Mass.) Veterans Administration Hospital.
Circulation: Cardiovascular Interventions fulfills the need for a prestigious journal devoted to this rapidly expanding field, according to Faxon.
"In the past, the most important papers in interventional cardiology appeared in general cardiology journals," Faxon said. "Today, at a time when at least 50 percent of cardiologists practice either invasive or interventional cardiology, clinicians and academicians need an excellent journal in this area."
The new journal's major objective will be to present the highest-quality original research from all areas of interventional cardiology - including coronary artery disease, such as angioplasty and stents; structural heart disease, including valvular and congenital heart disease; and vascular disease, including peripheral, aortic, renal and cerebral vascular disease.
"A priority will be placed on original research and on randomized trials and large registry studies that significantly advance the field," Faxon said.
Circulation: Cardiovascular Interventions will also feature timely reviews of cutting-edge advances, cardiac physiology and pathophysiology relevant to clinical practice and expert viewpoints on current controversies in interventional cardiology. Letters to the editors and imaging and case studies will provide a unique forum for the global interventional cardiology community.
"With the release of this fourth member of the Circulation portfolio of cardiovascular subspecialty journals, Circulation: Cardiovascular Interventions, the field of interventional cardiology will have an important new venue for publishing its outstanding studies," said Joseph Loscalzo, M.D., Editor-in-Chief of Circulation and the Circulation portfolio of journals. "With Dr. Dave Faxon as editor, this new journal promises to ascend rapidly to success in this important field of cardiovascular investigation and patient care."
Faxon encourages potential authors to submit their work for consideration for Circulation: Cardiovascular Interventions. "We're actively seeking top-quality research and other articles that further the practice and clinical outcomes of interventional cardiology," he said.
Information on submitting a manuscript can be found at http://circ.ahajournals.org/misc/ifora_interventions.shtml.
Circulation: Cardiovascular Interventions is designed to meet the growing demand for tightly focused information in areas at the cutting edge of cardiology. The first three journals of the Circulation portfolio of journals - Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, and Circulation: Cardiovascular Imaging - have commenced publication. The final two titles - Circulation: Cardiovascular Quality and Outcomes and Circulation: Cardiovascular Genetics - are scheduled to appear later in 2008.
Like the other Circulation portfolio journals, Circulation: Cardiovascular Interventions will be available in both print and online formats. The journal Web site, http://circinterventions.ahajournals.org, will launch when the first issue is posted in August and will also present "Publish Ahead of Print" articles and other online features.
American Heart Association/American Stroke Association Premium Professional members will have free, full-text access to journal articles through December 31, 2008. The first issue of each of the six new journals will be available to the public for free as sample issues.
NR08-1081 (Circ:Interv Launch)
Contact information: Dr. Faxon can be reached at (617) 525-8385 or email@example.com. (Please do not publish contact information.)
About the American Heart Association
Founded in 1924, the American Heart Association is the nation's oldest and largest voluntary health organization dedicated to building healthier lives, free of heart disease and stroke. These diseases, America's No. 1 and No. 3 killers, claim more than 870,000 lives a year. In fiscal year 2006-07 the association invested more than $554 million in research, professional and public education, advocacy and community service programs to help all Americans live longer, healthier lives. To learn more, call 1-800-AHA-USA1 or visit http://www.americanheart.org.
About Wolters Kluwer Health
Wolters Kluwer Health (Conshohocken, PA), a division of Wolters Kluwer, is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins [www.LWW.com] and Facts & Comparisons(R); electronic information providers, such as Ovid, Medi-Span(R) and ProVation; and pharmaceutical information providers such as Adis International and Source(R). Wolters Kluwer Health has annual revenues (2007) of $1,044 million (euro 761 million) and employs approximately 2,700 employees globally. For more information, visit http://www.WKHealth.com.
|SOURCE American Heart Association|
Copyright©2008 PR Newswire.
All rights reserved